Summarizing the incidence of adverse events using volcano plots and time intervals
Authors:
- 20 May 2013
- journal article
- Published by SAGE Publications in Clinical Trials
- Vol. 10 (3) , 398-406
Abstract
Background Adverse event incidence analyses are a critical component for describing the safety profile of any new intervention. The results typically are presented in lengthy summary tables. For therapeutic areas where patients have frequent adverse events, analysis and interpretation are made more difficult by the sheer number and variety of events that occur. Understanding the risk in these instances becomes even more crucial. Purpose We describe a space-saving graphical summary that overcomes the limitations of traditional presentations of adverse events and improves interpretability of the safety profile. Methods We present incidence analyses of adverse events graphically using volcano plots to highlight treatment differences. Data from a clinical trial of patients experiencing an aneurysmal subarachnoid hemorrhage are used for illustration. Adjustments for multiplicity are illustrated. Results Color is used to indicate the treatment with higher incidence; bubble size represents the total number of events that occur in the treatment arms combined. Adjustments for multiple comparisons are displayed in a manner to indicate clearly those events for which the difference between treatment arms is statistically significant. Furthermore, adverse events can be displayed by time intervals, with multiple volcano plots or animation to appreciate changes in adverse event risk over time. Such presentations can emphasize early differences across treatments that may resolve later or highlight events for which treatment differences may become more substantial with longer follow-up. Limitations Treatment arms are compared in a pairwise fashion. Conclusions Volcano plots are space-saving tools that emphasize important differences between the adverse event profiles of two treatment arms. They can incorporate multiplicity adjustments in a manner that is straightforward to interpret and, by using time intervals, can illustrate how adverse event risk changes over the course of a clinical trial.Keywords
This publication has 7 references indexed in Scilit:
- Flagging clinical adverse experiences: reducing false discoveries without materially compromising power for detecting true signalsStatistics in Medicine, 2012
- Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting teamClinical Trials, 2009
- Graphical approaches to the analysis of safety data from clinical trialsPharmaceutical Statistics, 2008
- Use of the false discovery rate for evaluating clinical safety dataStatistical Methods in Medical Research, 2004
- The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogasterNature Genetics, 2001
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society Series B: Statistical Methodology, 1995
- A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1993